Enhancements    

NEW CHEMOTHERAPY REGIMENS AND BIOMARKERS FOR CHAGAS DISEASE

NEW CHEMOTHERAPY REGIMENS AND BIOMARKERS FOR CHAGAS DISEASE
PI: Igor Almeida
Co-PI: Katja Michael
Sponsor: NIH - NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
Biological Sciences
Amount awarded: $6,064,237

This clinical trial study (1) tests new regimens of approved drugs for treating Chagas disease to improve their safety and efficacy; and (2) develops novel diagnostic tools that will provide a more efficient measure of disease state and treatment outcomes.

Posting date: Wed, 08/15/2018

Award start date: Fri, 06/01/2018
Award end date: Mon, 07/31/2023